Iradimed (IRMD) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Iradimed Corporation  (NASDAQ: IRMD)
 

Iradimed Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IRMD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 0.28 % 6.57 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) -6.88 % -1.87 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 11.21 % 7.21 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 0.07 % 1.5 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 21.45 % 10.68 % 8.65 % 10.59 %


IRMD's Growth Comparisons in II. Quarter 2026




Although the Medical Equipment & Supplies industry saw advancing Revenue by 6.57%, Iradimed announced 0.28% year on year sales decline in the second quarter 2026, to $ 20 millions, and underperformed the 8.91% Revenue growth in the Healthcare sector. Weak second quarter sales, in Medical Equipment & Supplies industry and within the Healthcare sector, were reflected in Iradimed Corporation results which underperformed overall market.

Top-line fell by -6.88% from the first quarter. Average annual sales growth for Iradimed is 21.45%, while S & P 500's average yearly sales increase is 10.59%, including only Businesses with the second quarter 2026 financial results.

IRMD Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
United States
91.01 %
92.76 %
MRI Compatible Intravenous IV Infusion Pump Systems
-5.97 %
0.46 %
MRI Compatible IV Infusion Pumps
-
-
MRI Compatible Patient Vital Signs Monitoring Systems
131.69 %
93.78 %
Services and other
-
35.86 %
Device Revenue
-
-
Disposable Revenue
-
-
Service
-
-
Total
0.28 %
-6.88 %


Growth Rates of IRMD's Income in the second quarter 2026


IRMD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) -5.85 % 11.6 % 4.62 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) -11.69 % 96.14 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) 15.74 % 13.68 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) -1.42 % 2.92 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - 11.5 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) -9.63 % -10.42 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) -10.31 % 19.69 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) 11.6 % 16.79 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) -2.35 % -2.7 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 75.02 % 5.35 % 0.17 % -28.52 %

IRMD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) -9.63 % -12.37 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) -10.31 % 44.98 % -0.77 % 27.07 %
Y / Y Net Income Change (Q2 TTM) 11.6 % -0.27 % 15.51 % 57.33 %
Sequential Net Income Change (Q2 TTM) -2.35 % -3.32 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth 75.02 % 4.12 % 9.21 % 22.96 %

IRMD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) -8.89 % -16.23 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) -10.87 % 15.71 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) 11.95 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) -2.15 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 74.31 % -1.8 % 0.17 % -28.52 %



IRMD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) -8.89 % -18.05 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) -8.89 % 40.16 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) -2.19 % - - 4.93 %
EPS Net 5 Year Avg. Change 73.91 % 4.12 % 9.21 % 22.96 %



Facing -8.89% year on year income per share decrease in the second quarter, to $ 0.41, Iradimed reported smaller declines than the Medical Equipment & Supplies industry with -18.05%, and less than -26.26% slide in the Healthcare sector. Slow second quarter 2026 income per share in Medical Equipment & Supplies industry and Healthcare sector, were portrayed in Iradimed's results, which underperformed overall market.

the bottom-line fell by -8.89% from the first quarter. Average annual income per share growth for Iradimed is 73.91%, while S & P 500's average yearly income per share increase is 22.96%, including only Businesses with the second quarter 2026 earnings.

IRMD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 20.67 % 63.77 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) -24.05 % -54.09 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) 87.44 % 39.68 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) 4.24 % 8.02 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change 26.11 % 3.81 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) -24.27 % - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - -9.69 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) -84.31 % 4.81 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) -5.54 % -21.5 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) -81.23 % -1.63 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) -47.88 % -1.55 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change 67.6 % 8.3 % 9.18 % 14.72 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.